Skip to content

ADD4KIDS White Paper Paves the Way for Demand-Driven Paediatric Innovation in Europe

The ADD4KIDS consortium has released a white paper titled "Fostering Collaboration for Paediatric Demand-Driven Innovation: Insights and Strategies from the ADD4KIDS Working Groups." This document consolidates the expertise of healthcare providers, policymakers, patient associations, and innovation specialists to address challenges in paediatric innovation procurement.

The ADD4KIDS consortium has unveiled a comprehensive White Paper titled “Fostering Collaboration for Paediatric Demand-Driven Innovation: Insights and Strategies from the ADD4KIDS Working Groups”.

This report brings together the collective expertise of healthcare providers, policymakers, patient associations, and innovation specialists to address the unique challenges of paediatric innovation procurement.

Designed as an essential resource for all stakeholders in paediatric healthcare innovation, the paper provides actionable insights and strategic recommendations to shape the future of demand-driven innovation in this critical field.

Key Highlights of the White Paper

  • Identifying Unmet Needs: Employing innovative strategies to recognise and address pressing paediatric challenges.
  • Enhancing Stakeholder Engagement: Cultivating effective partnerships and promoting cross-border collaborations to strengthen the paediatric innovation ecosystem.
  • Implementing Value-Based Procurement: Integrating demand-driven instruments to facilitate sustainable and impactful changes in paediatric healthcare.

About ADD4KIDS

ADD4KIDS is a 12-month EU-funded initiative aimed at optimising the utilisation of demand-driven funding instruments, such as Procurement of Innovation (PPI) and Value-Based Procurement (VBP), to overcome barriers hindering the adoption of paediatric innovations across Europe. The project aspires to create a holistic action plan to ensure the seamless implementation of these instruments, thereby enhancing the competitiveness and innovation potential of the European paediatric sector.

ADD4KIDS Consortium Partners

  1. Institut de Recerca Sant Joan de Déu – Fundació Sant Joan de Déu (FSJD-CERCA)
  2. Barcelona Children’s Hospital Sant Joan de Déu (HSJD)
  3. EIT Health
  4. The Children’s Memorial Health Institute (IPCZD)
  5. Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
  6. SCIENSANO
  7. The European Children’s Hospitals Organisation (ECHO)
  8. Inveniam Group

This collaborative effort underscores the consortium’s commitment to transforming paediatric healthcare through strategic, demand-driven innovation.

Related News

Featured

The paediatric innovation hub i4KIDS has received the 2024 National Award for the Promotion of Knowledge Transfer. The award ceremony took place at the Teatre Nacional de Catalunya, presided over by the President of the Government of Catalonia, Salvador Illa, with Minister Núria Montserrat acting as host. The award recognises i4KIDS’ transformative impact in transferring knowledge to the market and highlights its role in mobilising investment and generating value in the healthcare sector. The award was accepted by Arnau Valls and Dr Joan Comella, accompanied by a large delegation from Sant Joan de Déu Hospital.
i4KIDS Acceleration Programme

Featured

The i4KIDS acceleration programme kicks off its 2025 edition with seven innovative projects in fetal, paediatric, and maternal health. Five of these come from i4KIDS member organisations, while two are from the ITEMAS network. Over six months, they will receive training and mentoring in clinical validation and market access. The programme will conclude at the Pediatric Innovation Day on 20 November in Barcelona.
CRAASH 2025

Featured

i4KIDS has joined the 8th edition of the CRAASH Barcelona programme, led by Biocat, as a new strategic partner. This collaboration reinforces the commitment to paediatric health innovation by ensuring the inclusion of at least one project in this field. The initiative complements i4KIDS’ recently launched acceleration programme, with both offering distinct yet complementary goals: while i4KIDS supports early-stage projects (TRL 2–4) through tailored valorisation, CRAASH Barcelona focuses on more advanced solutions (TRL 3–6) and their clinical and market validation.